Compound Detail
CHEMBL2103743
TOFACITINIB CITRATE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O
Basic Information
| ChEMBL ID | CHEMBL2103743 |
| Name | TOFACITINIB CITRATE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | SYIKUFDOYJFGBQ-YLAFAASESA-N |
| Therapeutic | ✓ Yes |
| Parent Compound | CHEMBL221959 |
| Active Moiety | CHEMBL221959 |
33
Targets
155
Activities
3
Assay Types
9
PK Parameters
20
Publications
8
Known Names
6
Indications
1
Mechanisms
Molecular Properties
312.4
MW (Da)
1.54
ALogP
5
HBA
1
HBD
88.9
PSA (Ų)
0.93
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2012 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Janus Kinase (JAK) inhibitor | INHIBITOR | Janus Kinase (JAK) | ✓ | ✓ |
Indications
Arthritis, Psoriatic Arthritis, Rheumatoid Spondylitis, Ankylosing Dermatitis, Atopic Lupus Erythematosus, Discoid Lupus Erythematosus, Systemic
Drug Warnings
Black Box Warning
carcinogenicity
Black Box Warning
vascular toxicity
Black Box Warning
infectious disease
Activity Summary
IC50 105 meas. best 8.8
Kd 46 meas. best 9.7
Ki 4 meas. best 9.62
Target Activity Profile
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 22072.77 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 2217.9 | ng.hr.mL-1 | Mus musculus |
| AUC | 20929.46 | ng.hr.mL-1 | Mus musculus |
| AUC | 13432.34 | ng.hr.mL-1 | Mus musculus |
| AUC | 15712.71 | ng.hr.mL-1 | Mus musculus |
| AUC | 52073.75 | ng.hr.mL-1 | Mus musculus |
| Cmax | 54870.0 | nM | Rattus norvegicus |
| T1/2 | 3.94 | hr | Rattus norvegicus |
| Tmax | 0.42 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL5444388 | Tyrosine-protein kinase JAK1 | 24 |
| - | 10.6019/CHEMBL5444388 | Tyrosine-protein kinase JAK2 | 24 |
| - | 10.6019/CHEMBL5444388 | Tyrosine-protein kinase JAK3 | 24 |
| - | 10.6019/CHEMBL5444388 | Non-receptor tyrosine-protein kinase TYK2 | 24 |
| 35275619 | 10.1021/acs.jmedchem.1c02166 | Mus musculus | 13 |
| - | 10.6019/CHEMBL5724558 | Colon cancer organoid | 12 |
| - | 10.6019/CHEMBL5674860 | Colon cancer organoid | 12 |
| - | 10.6019/CHEMBL4689842 | U2OS | 10 |
| 35275619 | 10.1021/acs.jmedchem.1c02166 | ADMET | 9 |
| - | 10.6019/CHEMBL4689842 | HEK-293T | 8 |
| - | 10.6019/CHEMBL4689842 | Fibroblast | 7 |
| - | 10.6019/CHEMBL5608141 | Colon cancer organoid | 6 |
| 33691794 | 10.1186/s13148-021-01037-1 | A549 | 4 |
| - | 10.6019/CHEMBL5465560 | Tyrosine-protein kinase ABL1 | 3 |
| - | 10.6019/CHEMBL5465560 | Tyrosine-protein kinase JAK3 | 3 |
| - | 10.6019/CHEMBL5465560 | Tyrosine-protein kinase JAK2 | 3 |
| - | 10.6019/CHEMBL5465560 | Non-receptor tyrosine-protein kinase TYK2 | 3 |
| - | 10.6019/CHEMBL5465560 | Tyrosine-protein kinase Lck | 2 |
| - | 10.6019/CHEMBL5465560 | Serine/threonine-protein kinase DCLK3 | 2 |
| - | 10.6019/CHEMBL5465560 | Tyrosine-protein kinase JAK1 | 2 |
Data from ChEMBL 36 via Core Engine